澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ACTINOGEN MEDICAL LTD

0.057

-0.003-5.00%

成交量：296.32萬

成交額：17.03萬

市值：2.15億

市盈率：-12.35

高：0.060

開：0.060

低：0.057

收：0.060

52周最高：0.072

52周最低：0.028

股本：37.68億

流通股本：26.08億

量比：0.36

換手率：0.11%

股息：- -

股息率：- -

每股收益(TTM):-0.005

每股收益(LYR):-0.005

淨資產收益率：-77.46%

總資產收益率：-35.71%

市淨率：10.05

市盈率(LYR):-12.39

資料載入中...

總覽公司新聞資訊公告

Actinogen獲EMA積極科學建議，與其先前針對阿爾茨海默病項目獲得的FDA指導方向一致

Actinogen Medical本季度計劃與EMA會面探討簡化Xanamem歐盟審批路徑

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/ACW.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACW.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ACW.AU\",,,,,undefined,":{"symbol":"ACW.AU","market":"AU","secType":"STK","nameCN":"ACTINOGEN MEDICAL LTD","latestPrice":0.057,"timestamp":1789452720000,"preClose":0.06,"halted":0,"volume":2963207,"delay":0,"changeRate":-0.04999999999999993,"nameEN":"ACTINOGEN MEDICAL LTD","floatShares":2607880613,"shares":3768005775,"eps":-0.004615,"marketStatus":"未開盤","change":-0.003,"latestTime":"09-15 16:12:00 AEST","open":0.06,"high":0.06,"low":0.057,"amount":170300,"amplitude":0.05,"askPrice":0.058,"askSize":41203,"bidPrice":0.057,"bidSize":100144,"shortable":3,"etf":0,"ttmEps":-0.004615,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789516800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.06,"openAndCloseTimeList":[[1789430400000,1789452000000]],"volumeRatio":0.358599,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ACW.AU","preClose":0.06,"auctionPrice":0.057,"auctionVolume":2100,"auction":3,"marketStatus":"盘后竞价","timestamp":1789452593495}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ACW.AU\",,,,,undefined,":{"symbol":"ACW.AU","floatShares":2607880613,"roa":"-35.71%","roe":"-77.46%","lyrEps":-0.0046,"volumeRatio":0.358599,"shares":3768005775,"dividePrice":0,"high":0.06,"amplitude":0.05,"preClose":0.06,"low":0.057,"week52Low":0.028,"pbRate":"10.05","psRate":"16.95","week52High":0.072,"institutionHeld":0,"latestPrice":0.057,"committee":0.416995,"eps":-0.004615,"divideRate":0,"volume":2963207,"delay":0,"ttmEps":-0.004615,"open":0.06,"prevYearClose":0.061,"prevWeekClose":0.06,"prevMonthClose":0.043,"prevQuarterClose":0.031,"fiveDayClose":0.063,"twentyDayClose":0.044,"sixtyDayClose":0.033,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACW.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2020-10-19","symbol":"ACW.AU","defaultRemindTime":1603062000000,"type":"split","dateTimestamp":1603026000000,"forFactor":98,"toFactor":100,"ratio":0.98}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACW.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACW.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1128108625","title":"Actinogen獲EMA積極科學建議，與其先前針對阿爾茨海默病項目獲得的FDA指導方向一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1128108625","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128108625?lang=zh_tw&edition=fundamental","pubTime":"2026-05-28 20:03","pubTimestamp":1779969792,"startTime":"0","endTime":"0","summary":"Actinogen Medical Ltd. 在推进其阿尔茨海默病治疗项目方面取得了重要进展。该公司宣布，已获得欧洲药品管理局（EMA）的积极科学建议，该建议与此前美国食品药品监督管理局（FDA）提供的指导方向保持一致。\n这一积极反馈为该公司关键临床项目的下一步发展路径提供了明确的监管支持。获得两大主要监管机构在科学和监管策略上的一致性认可，显著增强了该药物开发计划的可预测性与成功前景。\n对于专注于神经退行性疾病领域的生物技术公司而言，此类监管协同至关重要。它不仅能优化全球开发策略，还可能加速未来在多个主要市场的审评进程。此次进展预计将进一步提升投资者对该项目及其长期潜力的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","ACW.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160930623","title":"Actinogen Medical本季度計劃與EMA會面 探討簡化Xanamem歐盟審批路徑","url":"https://stock-news.laohu8.com/highlight/detail?id=1160930623","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160930623?lang=zh_tw&edition=fundamental","pubTime":"2026-04-01 20:35","pubTimestamp":1775046911,"startTime":"0","endTime":"0","summary":"生物制药公司Actinogen Medical Ltd宣布，将在本季度与欧洲药品管理局（EMA）举行会议。此次会晤的核心议题是探讨如何优化和简化其主打候选药物Xanamem在欧盟地区的审批流程，旨在加速该药物的上市进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACW.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}